# Lapatinib and Circulating Tumor Cells in Breast Cancer

> **NCT00694252** · PHASE2 · COMPLETED · sponsor: **University Hospital of Crete** · enrollment: 20 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Lapatinib

## Key facts

- **NCT ID:** NCT00694252
- **Lead sponsor:** University Hospital of Crete
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694252, "Lapatinib and Circulating Tumor Cells in Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00694252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*